These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28670746)

  • 1. HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: A case report.
    Cabel L; Bidard FC; Servois V; Cacheux W; Mariani P; Romano E; Minsat M; Bieche I; Farkhondeh F; Jeannot E; Buecher B
    Int J Cancer; 2017 Oct; 141(8):1667-1670. PubMed ID: 28670746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study.
    Morris VK; Salem ME; Nimeiri H; Iqbal S; Singh P; Ciombor K; Polite B; Deming D; Chan E; Wade JL; Xiao L; Bekaii-Saab T; Vence L; Blando J; Mahvash A; Foo WC; Ohaji C; Pasia M; Bland G; Ohinata A; Rogers J; Mehdizadeh A; Banks K; Lanman R; Wolff RA; Streicher H; Allison J; Sharma P; Eng C
    Lancet Oncol; 2017 Apr; 18(4):446-453. PubMed ID: 28223062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders.
    Huffman BM; Singh H; Ali LR; Horick N; Wang SJ; Hoffman MT; Metayer KA; Murray S; Bird A; Abrams TA; Biller LH; Chan JA; Meyerhardt JA; McCleary NJ; Goessling W; Patel AK; Wisch JS; Yurgelun MB; Mouw K; Reardon B; Van Allen EM; Zerillo JA; Clark JW; Parikh A; Mayer RJ; Schlechter B; Ng K; Kumar S; Del Vecchio Fitz C; Kuperwasser C; Hanna GJ; Coveler AL; Rubinson DA; Welsh EL; Pfaff K; Rodig S; Dougan SK; Cleary JM
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38272561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 Trial.
    Bernard-Tessier A; Jeannot E; Guenat D; Debernardi A; Michel M; Proudhon C; Vincent-Salomon A; Bièche I; Pierga JY; Buecher B; Meurisse A; François É; Cohen R; Jary M; Vendrely V; Samalin E; El Hajbi F; Baba-Hamed N; Borg C; Bidard FC; Kim S
    Clin Cancer Res; 2019 Apr; 25(7):2109-2115. PubMed ID: 30504426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma.
    Cabel L; Jeannot E; Bieche I; Vacher S; Callens C; Bazire L; Morel A; Bernard-Tessier A; Chemlali W; Schnitzler A; Lièvre A; Otz J; Minsat M; Vincent-Salomon A; Pierga JY; Buecher B; Mariani P; Proudhon C; Bidard FC; Cacheux W
    Clin Cancer Res; 2018 Nov; 24(22):5767-5771. PubMed ID: 30054279
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-Telomerase CD4
    Spehner L; Kim S; Vienot A; François E; Buecher B; Adotevi O; Vernerey D; Abdeljaoued S; Meurisse A; Borg C
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal.
    Morris VK; Rashid A; Rodriguez-Bigas M; Das P; Chang G; Ohinata A; Rogers J; Crane C; Wolff RA; Eng C
    Oncologist; 2015 Nov; 20(11):1247-52. PubMed ID: 26382740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Squamous cell anal carcinoma. What's next ?].
    Kim S; Spehner L; Cabel L; Bidard FC; Borg C
    Bull Cancer; 2021 Jan; 108(1):80-89. PubMed ID: 33423780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promise of immunotherapy in anal squamous cell carcinoma: a novel approach for an orphan disease.
    Johnson B; Eng C
    Clin Adv Hematol Oncol; 2017 Dec; 15(12):968-961. PubMed ID: 29315288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus-related squamous cell carcinoma of the anal canal with papillary features.
    Leon ME; Shamekh R; Coppola D
    World J Gastroenterol; 2015 Feb; 21(7):2210-3. PubMed ID: 25717259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in the treatment of anal cancer: an overview of the latest investigational drugs.
    Yu J; Kim RD
    Expert Opin Investig Drugs; 2024 Feb; 33(2):145-157. PubMed ID: 38275174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent association of human papillomavirus 16 and 18 DNA with anal squamous cell and basaloid carcinoma.
    Vincent-Salomon A; de la Rochefordière A; Salmon R; Validire P; Zafrani B; Sastre-Garau X
    Mod Pathol; 1996 Jun; 9(6):614-20. PubMed ID: 8782197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological Checkpoint Blockade in Anal Squamous Cell Carcinoma: Dramatic Responses Tempered By Frequent Resistance.
    Jayakrishnan T; Yadav D; Huffman BM; Cleary JM
    Curr Oncol Rep; 2024 Aug; 26(8):967-976. PubMed ID: 38861124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Immunotherapy in the Treatment of Squamous Cell Carcinoma of the Anal Canal.
    Morris VK; Eng C
    J Natl Compr Canc Netw; 2018 Jul; 16(7):903-908. PubMed ID: 30006430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a Phase I study of ZYC101.
    Klencke B; Matijevic M; Urban RG; Lathey JL; Hedley ML; Berry M; Thatcher J; Weinberg V; Wilson J; Darragh T; Jay N; Da Costa M; Palefsky JM
    Clin Cancer Res; 2002 May; 8(5):1028-37. PubMed ID: 12006515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy in Anal Cancer.
    Phuong L; Rajdev L
    Curr Oncol Rep; 2020 Jul; 22(9):94. PubMed ID: 32651760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV positive, wild type TP53, and p16 overexpression correlate with the absence of residual tumors after chemoradiotherapy in anal squamous cell carcinoma.
    Soares PC; Abdelhay ES; Thuler LCS; Soares BM; Demachki S; Ferro GVR; Assumpção PP; Lamarão LM; Ribeiro Pinto LF; Burbano RMR
    BMC Gastroenterol; 2018 Feb; 18(1):30. PubMed ID: 29466950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy.
    Yhim HY; Lee NR; Song EK; Kwak JY; Lee ST; Kim JH; Kim JS; Park HS; Chung IJ; Shim HJ; Hwang JE; Kim HR; Nam TK; Park MR; Shim H; Park HS; Kim HS; Yim CY
    Int J Cancer; 2011 Oct; 129(7):1752-60. PubMed ID: 21128253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune microenvironment and HPV in anal cancer: Rationale to complement chemoradiation with immunotherapy.
    Martin D; Rödel F; Balermpas P; Rödel C; Fokas E
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):221-230. PubMed ID: 28501560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple human papillomavirus infections are highly prevalent in the anal canal of human immunodeficiency virus-positive men who have sex with men.
    Méndez-Martínez R; Rivera-Martínez NE; Crabtree-Ramírez B; Sierra-Madero JG; Caro-Vega Y; Galván SC; de León DC; García-Carrancá A
    BMC Infect Dis; 2014 Dec; 14():671. PubMed ID: 25510243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.